← Leaderboards
Fabienne Gally
National Jewish Health
$3,162,899
Attributed
$3,162,899
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $597.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,162,899 · 1
By mechanism
R01$3,162,899 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- Susan M Majka$13,999,914
- Karina Serban$2,991,972
- Pumin Zhang$10,272,674
- Ivana V Yang$13,155,768
- Patrick Scott Hume$703,262
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingPpar GammaInfectionMacrophageMonocytePathogenesisFatty AcidsImpairmentInflammatoryLungEnhancersBindingNuclear ReceptorsOxidationCigarette SmokingFatty Acid-Binding ProteinsFlareClinically RelevantAlveolar MacrophagesInflammationIn VivoLinkCigarette SmokePublic Health Relevance
Grant awards (6)
Role of FABP5 in COPD Exacerbations$591,985
R01 · FY2025 · HL · contact PI
Role of FABP5 in COPD Exacerbations$597,510
R01 · FY2024 · HL · contact PI
Role of FABP5 in COPD Exacerbations$495,444
R01 · FY2022 · HL · contact PI
Role of FABP5 in COPD Exacerbations$494,460
R01 · FY2021 · HL · contact PI
Role of FABP5 in COPD Exacerbations$492,000
R01 · FY2020 · HL · contact PI
Role of FABP5 in COPD Exacerbations$491,500
R01 · FY2019 · HL · contact PI